Abstract
This paper argues that the concepts of therapeutic equivalence and noninferiority trials have some unclear logic and give results that might not be in accordance with clinical experience. They are also totally unnecessary. The discussion focuses on therapeutic equivalence trials, but carries over directly to noninferiority trials. Therapeutic equivalence proves to be a flexible tool for delusion and should be abandoned. Statistics should end where it can claim to be correct and useful, in this case, with estimates and confidence limits of clinically relevant parameters such as relative dose potency. If therapeutic equivalence is still needed for special purposes, the testing and definition should be done on the dose scale.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
ICH Harmonised Tripartite Guideline. Statistical principles in clinical trials. Stat Med. 1999; 18:1905–1942.
Rohmel J. Therapeutic equivalence investigations: statistical considerations. Stat Med. 1998;17:1703–1714.
FDC Reports, The pink sheets. May 6, 1991;53(18): 14-15.
Kallen A, Larsson P. Dose response studies: how do we make them conclusive? Stat Med. 1999; 18: 629–641.
Ahrens RC, et al. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methcholine. Am J Respir Crit Care Med. 1999;160:1238–1243.
Parameswaran KN, et al. Protection against metha-choline bronchoconstriction to assess relative potency of inhaled pYagonists. Am J Respir Crit Care Med. 1999;160:354–357.
Senn SJ. Statistical issues in Drug Development. Chichester: John Wiley; 1997.
Finney DJ. Statistical Methods in Biological Assay. London, UK: Griffin; 1978.
Govindarajulu Z. Statistical Techniques in Bioassay. Basel, Switzerland: Karger; 2001.
Senn SJ, et al. An incomplete blocks cross-over in asthma: a case study in collaboration. Cross-over Clinical Trials. J. Vollmar, L.A. Hothorn, eds. Stuttgart: Fischer; 1997:3–26.
Boulet LP, et al. Comparison of Diskus’ inhaler, a new multidose powder inhaler, with Diskhaler™ inhaler for the delivery of Salmeterol to asthmatic patients. J Asthma. 1995;32(6):429–436.
Ebbutt AF, Frith L. Practical issues in equivalence trials. Stat Med. 1998;17:1691–1701.
Senn SJ. Statistical issues in short term trials in asthma. Drug Inf J. 1993;27:779–791.
Rott Z, Bocskei C, Poszi M, Juhasz G, Larsson P, Rosenborg J. On the relative therapeutic index between formoterol Turbuhaler and Salbutamol pressurized metered dose (pMDI) inhaler in asthmatic patients. Eur Respir J. 1998;12:suppl 28:324s.
Bates DM, Watts DG. Nonlinear Regression Analysis and its Applications. New York, NY: John Wiley and Sons; 1988.
Hamasaki T, et al. Statistical approaches to detect dose-response relationships. Drug Inf J. 2000;34: 579–590.
Kallen A, Larsson P. On the definition of therapeutic equivalence. Drug Inf J. 2000;34:349–354.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Källén, A. A Note on Therapeutic Equivalence and Therapeutic Ratio with Application to Studies in Respiratory Diseases. Ther Innov Regul Sci 35, 1495–1505 (2001). https://doi.org/10.1177/009286150103500444
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286150103500444